PDS Intangible Assets from 2010 to 2026
| PDSB Stock | USD 0.73 0.04 5.19% |
Intangible Assets | First Reported 2010-12-31 | Previous Quarter 37.5 K | Current Value 37.4 K | Quarterly Volatility 5.7 K |
Check PDS Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PDS Biotechnology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 57.5 K, Interest Expense of 5.6 M or Other Operating Expenses of 29.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.95. PDS financial statements analysis is a perfect complement when working with PDS Biotechnology Valuation or Volatility modules.
PDS | Intangible Assets | Build AI portfolio with PDS Stock |
Analyzing PDS Biotechnology's Intangible Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Intangible Assets has evolved provides context for assessing PDS Biotechnology's current valuation and future prospects.
Latest PDS Biotechnology's Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of PDS Biotechnology Corp over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. PDS Biotechnology's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PDS Biotechnology's overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
PDS Intangible Assets Regression Statistics
| Arithmetic Mean | 45,708 | |
| Geometric Mean | 45,373 | |
| Coefficient Of Variation | 12.46 | |
| Mean Deviation | 5,243 | |
| Median | 41,692 | |
| Standard Deviation | 5,697 | |
| Sample Variance | 32.5M | |
| Range | 14.5K | |
| R-Value | (0.93) | |
| Mean Square Error | 4.9M | |
| R-Squared | 0.86 | |
| Slope | (1,045) | |
| Total Sum of Squares | 519.3M |
PDS Intangible Assets History
About PDS Biotechnology Financial Statements
PDS Biotechnology stakeholders use historical fundamental indicators, such as PDS Biotechnology's Intangible Assets, to determine how well the company is positioned to perform in the future. Although PDS Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in PDS Biotechnology's assets and liabilities are reflected in the revenues and expenses on PDS Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PDS Biotechnology Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 37.5 K | 37.4 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out the analysis of PDS Biotechnology Correlation against competitors. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. Anticipated expansion of PDS directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive PDS Biotechnology assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate PDS Biotechnology Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating PDS Biotechnology's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause PDS Biotechnology's market price to deviate significantly from intrinsic value.
It's important to distinguish between PDS Biotechnology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PDS Biotechnology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, PDS Biotechnology's market price signifies the transaction level at which participants voluntarily complete trades.